Stock Price Movement and Market Context
On 16 Mar 2026, Lasa Supergenerics Ltd’s stock price continued its slide, underperforming the Pharmaceuticals & Biotechnology sector by 0.65%. The stock has declined for three consecutive trading sessions, accumulating a loss of 10.16% over this period. It currently trades below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling sustained bearish sentiment among market participants.
In comparison, the broader market showed resilience, with the Nifty index closing at 23,408.80, up 1.11% for the day. However, the Nifty itself is trading below its 50-day moving average, which remains under the 200-day moving average, indicating a cautious market environment. Notably, the Nifty Realty and S&P BSE Realty indices also hit new 52-week lows on the same day, reflecting sector-specific pressures.
Long-Term Performance and Valuation Metrics
Over the past year, Lasa Supergenerics Ltd has delivered a return of -65.09%, significantly lagging behind the Sensex, which posted a positive 2.27% return during the same period. The stock’s 52-week high was Rs 23.33, underscoring the steep decline in valuation. The company is classified as a micro-cap with a Mojo Score of 3.0 and a Mojo Grade recently downgraded from Sell to Strong Sell on 11 Feb 2025.
The stock’s price-to-earnings-growth (PEG) ratio stands at 1.4, reflecting a valuation that is risky relative to its historical averages. Despite a 101.8% increase in profits over the last year, the stock’s price has not responded positively, indicating market scepticism about the company’s fundamentals and outlook.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Financial Health and Profitability Concerns
Lasa Supergenerics Ltd’s financial metrics reveal ongoing challenges. The company reported net sales of Rs 5.26 crores in the latest six-month period, representing a sharp contraction of 92.74%. The quarterly profit after tax (PAT) stood at a loss of Rs 2.55 crores, down 17.3% compared to previous periods. These figures highlight a significant downturn in revenue generation and profitability.
The company’s ability to service its debt remains weak, with an average EBIT to interest ratio of -5.16, indicating that earnings before interest and tax are insufficient to cover interest expenses. Return on equity (ROE) averages at 3.54%, signalling low profitability relative to shareholders’ funds. Negative EBITDA further accentuates the financial strain, contributing to the stock’s classification as risky.
Technical Indicators Reflect Bearish Sentiment
Technical analysis corroborates the downward trend. Weekly and monthly Moving Average Convergence Divergence (MACD) indicators are bearish and mildly bullish respectively, while the Relative Strength Index (RSI) shows no clear signal. Bollinger Bands on both weekly and monthly charts indicate bearish momentum. Daily moving averages remain firmly bearish, supported by negative signals from the KST and Dow Theory indicators on weekly and monthly timeframes. On-balance volume (OBV) readings are mildly bearish, suggesting subdued buying interest.
The stock’s consistent underperformance against the BSE500 benchmark over the past three years further emphasises the challenges faced by Lasa Supergenerics Ltd in regaining investor confidence and market traction.
Considering Lasa Supergenerics Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Shareholding and Market Capitalisation
The majority shareholding in Lasa Supergenerics Ltd is held by promoters, reflecting concentrated ownership. The company’s micro-cap status places it among smaller listed entities, which often face higher volatility and liquidity constraints compared to larger peers.
Despite the current valuation pressures and subdued market performance, the stock remains under close observation due to its sector affiliation and financial metrics.
Summary of Key Metrics
To summarise, Lasa Supergenerics Ltd’s stock is trading near its 52-week low of Rs 7.13, with a closing price just 0.42% above this level. The stock has declined over 65% in the past year, underperforming the Sensex and BSE500 indices consistently. Financial results show a steep decline in net sales and a negative PAT, alongside weak debt servicing capacity and low return on equity. Technical indicators predominantly signal bearish trends, reinforcing the current downtrend.
The broader market environment shows mixed signals, with mega-cap stocks leading gains while certain sectoral indices, including realty, also hit new lows. Lasa Supergenerics Ltd’s micro-cap status and financial profile contribute to its classification as a strong sell with a Mojo Grade of 3.0.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
